Biosciences Innovator Launches Fundraising Round After Successful Pre-Clinical Results for Fibrosis Treatment
Dupuytren’s is a common, progressive, debilitating fibrosis of the hands. Ventoux Biosciences is on a mission to develop new treatment options.